Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | SMi Group announce 6th annual RNAi, miRNA and siRNA conference, 27th & 28th June 2011Join the top 50 Pharma companies as they discuss some of the most prominent issues that stand in the way of the successful harnessing of the vast potential that this process possesses.
By: SMi Group Learn how top pharma companies are utilising RNAi potential at SMi’s RNAi, miRNA and siRNA. RNAi holds vast potential for the pharmaceutical and biotechnology industry. However now is a crucial time in the development of this exiting area of research, where knowledge and contacts are key to preserving, and building upon, your existing programmes in nucleic acid delivery and inference. It is vital that remaining budgets are utilised in effective ways, new technology and breakthroughs are investigated, and investments are protected by informed decision making. Key topics include: • The latest successes in miRNA, siRNA and oligonucleotide therapeutic development • Tackling delivery issues • Clinical trial considerations • Regulatory issues • Bioinformatics and computational support. • Epigenetics • KOL Panel Discussion: The effect of pharma cuts on the further development and commercialisation of RNAi technologies For more information on the conference and workshop visit http://www.smi- # # # About SMi Group RNAi, miRNA and siRNA is just one of the many conferences that are a part of the SMi Group portfolio. The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk For further information, contact: Patrick Bedwei Tel: +44 (0) 20 7827 6151 Email: pbedwei@smi- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|